Showing results (1531-1540 of 1,827) with videos related to

Sort By:
Pageof 183
Molecules (Basel, Switzerland)|September 23, 2022
Effects of Medicinal Leech-Related Cationic Antimicrobial Peptides on Human Blood Cells and PlasmaTatyana V Vakhrusheva, Grigoriy D Moroz, Liliya Yu Basyreva, et al.
Journal of Medicinal Chemistry|June 11, 2004
Novel pyridazino[4,3-b]indoles with dual inhibitory activity against Mycobacterium tuberculosis and monoamine oxidaseValeriya S Velezheva, Patrick J Brennan, Vladimir Yu Marshakov, et al.
Nanomaterials (Basel, Switzerland)|March 26, 2025
The Composition of the Dispersion Medium Determines the Antibacterial Properties of Copper (II) Oxide Nanoparticles Against Escherichia coli BacteriaOlga V Zakharova, Alexander A Gusev, Peter A Baranchikov, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|February 22, 2007
[An association between the FABP2 gene polymorphism and efficacy of valproates]M G Aksenova, S G Burd, E Iu Kachalin, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|September 16, 2006
[Batroxobin in patients with ischemic stroke in the carotid system (the multicenter study)]E I Gusev, V I Skvortsova, Z A Suslina, et al.
Problemy Endokrinologii|May 1, 1990
[Testosterone metabolism in discrete areas of the brain in rat fetuses]A G Reznikov, I G Akmaev, O F Fidelina, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|January 1, 1997
[Genetic predisposition factors for multiple sclerosis (based on the data from genotyping patients of the Russian ethnic group)]E I Gusev, M A Sudomoina, A N Boĭko, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|November 7, 2009
[Pathogenetic treatment of multiple sclerosis: the present and the future]A N Boĭko, I D Stoliarov, T V Sidorenko, et al.
Pageof 183